Alyeska Investment Group, L.P.

Holdings History for Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Symbol: ALGS on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 530,000 shares
Security Ownership %: 10%

Shares, Excluding Options vs Price

Value, Excluding Options

Alyeska Investment Group, L.P. ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

15 May 2025 - Alyeska Investment Group, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 530,000 shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS). This represents 10% ownership of the company. This is the first filing by Alyeska Investment Group, L.P. disclosing ownership of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Alyeska Investment Group, L.P.	10%		$2,809,000	530,000			$5.30	13G	31 Mar 2025	15 May 2025, 16:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	0%	$3,839,840	412,000	0		$9.32	Q4 2025
30 Sep 2025	0.01%	0%	$4,037,600	412,000	0		$9.80	Q3 2025
30 Jun 2025	0.01%	0%	$2,970,520	412,000	0		$7.21	Q2 2025
31 Mar 2025	0.01%	+0.01%	$3,399,000	412,000	+412,000	NEW	$8.25	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.